{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:01:37Z","timestamp":1789718497810,"version":"4.0.1"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["DEC-2021\/43\/I\/NZ7\/00342"],"award-info":[{"award-number":["DEC-2021\/43\/I\/NZ7\/00342"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cancer therapy-related cognitive impairment (CRCI) is a frequent complication of cancer treatment. It involves multiple biological mechanisms: neuroinflammation, oxidative stress, mitochondrial dysfunction, impaired neurogenesis, and altered brain connectivity. Although these mechanisms have been extensively studied, evidence across cytotoxic chemotherapy, endocrine therapy, and targeted therapies is often presented separately. This review is the first of a two-part series addressing the mechanisms underlying CRCI and current and emerging therapeutic strategies for its prevention and management. It integrates available clinical and mechanistic research results across treatment classes, highlighting shared biological pathways, biomarkers, neuroimaging findings, and objective\n                    <jats:italic>versus<\/jats:italic>\n                    subjective cognitive outcomes to provide a comprehensive overview of CRCI.\n                  <\/jats:p>","DOI":"10.1007\/s43440-026-00902-1","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:44:06Z","timestamp":1789670646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer therapy-related cognitive impairment, part 1: an integrative clinical\u2013mechanistic framework from phenotypes to convergent neurobiological pathways"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6086-191X","authenticated-orcid":false,"given":"Selene","family":"Tertemiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9866-5777","authenticated-orcid":false,"given":"Jan","family":"Detka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-5393","authenticated-orcid":false,"given":"Kinga","family":"Sa\u0142at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"902_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12885-025-13862-1","volume":"25","author":"M Elmadani","year":"2025","unstructured":"Elmadani M, Mokaya PO, Omer AAA, Kiptulon EK, Klara S, Orsolya M. Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022). BMC Cancer. 2025;25:447.","journal-title":"BMC Cancer"},{"key":"902_CR2","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.3390\/molecules25235776","volume":"25","author":"Z Dembic","year":"2020","unstructured":"Dembic Z, Paveli\u0107 K, Kraljevi\u0107 Paveli\u0107 S, Duarte Ciceco IF. Antitumor drugs and their targets. Molecules. 2020;25:5776.","journal-title":"Molecules"},{"key":"902_CR3","doi-asserted-by":"publisher","first-page":"e2138793","DOI":"10.1001\/jamanetworkopen.2021.38793","volume":"4","author":"T Olivier","year":"2021","unstructured":"Olivier T, Haslam A, Prasad V. Anticancer drugs approved by the US Food and Drug Administration from 2009 to 2020 according to their mechanism of action. JAMA Netw Open. 2021;4:e2138793.","journal-title":"JAMA Netw Open"},{"key":"902_CR4","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/cancers17142401","volume":"17","author":"U Farooq","year":"2025","unstructured":"Farooq U, Li J, Chang Z. Disrupting cell cycle machinery: CREPT is an emerging target in cancer therapy. Cancers. 2025;17:2401.","journal-title":"Cancers"},{"key":"902_CR5","first-page":"1","volume":"14","author":"J Nicke","year":"2024","unstructured":"Nicke J. Navigating the landscape of anticancer drugs: mechanisms, administration, and challenges. Intern Med Open Access. 2024;14:1\u20132.","journal-title":"Intern Med Open Access"},{"key":"902_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12935-023-02990-y","volume":"23","author":"M Araghi","year":"2023","unstructured":"Araghi M, Mannani R, Heidarnejad Maleki A, Hamidi A, Rostami S, Safa SH, et al. Recent advances in non-small cell lung cancer targeted therapy: an update review. Cancer Cell Int. 2023;23:181.","journal-title":"Cancer Cell Int"},{"key":"902_CR7","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1021\/acschemneuro.1c00338","volume":"12","author":"A Umfress","year":"2021","unstructured":"Umfress A, Speed HE, Tan C, Ramezani S, Birnbaum S, Brekken RA, et al. Neuropathological effects of chemotherapeutic drugs. ACS Chem Neurosci. 2021;12:3038.","journal-title":"ACS Chem Neurosci"},{"key":"902_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/15384101.2017.1334022","volume":"16","author":"A Kovalchuk","year":"2017","unstructured":"Kovalchuk A, Kolb B. Chemo brain: From discerning mechanisms to lifting the brain fog - an aging connection. Cell Cycle. 2017;16:1345\u20139.","journal-title":"Cell Cycle"},{"key":"902_CR9","doi-asserted-by":"publisher","first-page":"750507","DOI":"10.3389\/fphar.2022.750507","volume":"13","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, et al. Mechanisms of chemotherapy-induced neurotoxicity. Front Pharmacol. 2022;13:750507.","journal-title":"Front Pharmacol"},{"key":"902_CR10","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41588-025-02234-x","volume":"57","author":"E Mitchell","year":"2025","unstructured":"Mitchell E, Pham MH, Clay A, Sanghvi R, Williams N, Pietsch S, et al. The long-term effects of chemotherapy on normal blood cells. Nat Genet. 2025;57:1684\u201394.","journal-title":"Nat Genet"},{"key":"902_CR11","first-page":"308","volume":"75","author":"NS Wagle","year":"2025","unstructured":"Wagle NS, Nogueira L, Devasia TP, Mariotto AB, Yabroff KR, Islami F, et al. Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin. 2025;75:308\u201330.","journal-title":"CA Cancer J Clin"},{"key":"902_CR12","first-page":"18","volume":"70","author":"AJM Beijers","year":"2012","unstructured":"Beijers AJM, Jongen JLM, Vreugdenhil G. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med. 2012;70:18\u201325.","journal-title":"Neth J Med"},{"key":"902_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"S Quasthoff","year":"2002","unstructured":"Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249:9\u201317.","journal-title":"J Neurol"},{"key":"902_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/s-0035-1558983","volume":"35","author":"J Dineen","year":"2015","unstructured":"Dineen J, Freeman R. Autonomic neuropathy. Semin Neurol. 2015;35:458\u201368.","journal-title":"Semin Neurol"},{"key":"902_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/B978-0-444-53502-3.00031-8","volume":"105","author":"HB Newton","year":"2012","unstructured":"Newton HB. Neurological complications of chemotherapy to the central nervous system. Handb Clin Neurol. 2012;105:903\u201316.","journal-title":"Handb Clin Neurol"},{"key":"902_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12026-022-09307-7","volume":"70","author":"P Gupta","year":"2022","unstructured":"Gupta P, Makkar TK, Goel L, Pahuja M. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity. Immunol Res. 2022;70:725\u201341.","journal-title":"Immunol Res"},{"key":"902_CR17","doi-asserted-by":"publisher","first-page":"e071726","DOI":"10.1136\/bmj-2022-071726","volume":"380","author":"B Fleming","year":"2023","unstructured":"Fleming B, Edison P, Kenny L. Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management. BMJ. 2023;380:e071726.","journal-title":"BMJ"},{"key":"902_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13244-023-01602-7","volume":"15","author":"MFG Isaac","year":"2024","unstructured":"Isaac MFG, Alkhatib R, Ho CL. MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review. Insights Imaging. 2024;15:12.","journal-title":"Insights Imaging"},{"key":"902_CR19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/ph16081165","volume":"16","author":"PK Jaiswara","year":"2023","unstructured":"Jaiswara PK, Shukla SK. Chemotherapy-mediated neuronal aberration. Pharmaceuticals. 2023;16:1165.","journal-title":"Pharmaceuticals"},{"key":"902_CR20","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1200\/JCO.2011.37.0189","volume":"30","author":"V Koppelmans","year":"2012","unstructured":"Koppelmans V, Breteler MMB, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol. 2012;30:1080\u20136.","journal-title":"J Clin Oncol"},{"key":"902_CR21","doi-asserted-by":"publisher","first-page":"ii54","DOI":"10.1093\/ndt\/gfae249","volume":"40","author":"M Simeoni","year":"2025","unstructured":"Simeoni M, Mulholland MM, Workeneh BT, Capasso A, Hafez G, Liabeuf S, et al. Chemotherapy-related cognitive impairment and kidney dysfunction. Nephrol Dial Transpl. 2025;40:ii54\u201363.","journal-title":"Nephrol Dial Transpl"},{"key":"902_CR22","doi-asserted-by":"publisher","first-page":"1387251","DOI":"10.3389\/fonc.2024.1387251","volume":"14","author":"K Demos-Davies","year":"2024","unstructured":"Demos-Davies K, Lawrence J, Seelig D. Cancer related cognitive impairment: a downside of cancer treatment. Front Oncol. 2024;14:1387251.","journal-title":"Front Oncol"},{"key":"902_CR23","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.bbih.2025.101161","volume":"51","author":"W Chen","year":"2025","unstructured":"Chen W, Johnston IN. A systematic review of the neurobiological mechanisms of chemotherapy-induced deficits in executive functions. Brain Behav Immun Health. 2025;51:101161.","journal-title":"Brain Behav Immun Health"},{"key":"902_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1176\/ajp.137.5.597","volume":"137","author":"PM Silberfarb","year":"1980","unstructured":"Silberfarb PM, Philibert D, Levine PM. Psychosocial aspects of neoplastic disease: II. affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry. 1980;137:597\u2013601.","journal-title":"Am J Psychiatry"},{"key":"902_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/cncr.20393","volume":"101","author":"JS Wefel","year":"2004","unstructured":"Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. Chemobrain in breast carcinoma? A prologue. Cancer. 2004;101:466\u201375.","journal-title":"Cancer"},{"key":"902_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.acr.2022.04.001","volume":"155","author":"V Rao","year":"2022","unstructured":"Rao V, Bhushan R, Kumari P, Cheruku SP, Ravichandiran V, Kumar N. Chemobrain: A review on mechanistic insight, targets and treatments. Adv Cancer Res. 2022;155:29\u201376.","journal-title":"Adv Cancer Res"},{"key":"902_CR27","doi-asserted-by":"publisher","first-page":"e12075","DOI":"10.15252\/emmm.202012075","volume":"12","author":"LD Nguyen","year":"2020","unstructured":"Nguyen LD, Ehrlich BE. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med. 2020;12:e12075.","journal-title":"EMBO Mol Med"},{"key":"902_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/med.21977","volume":"44","author":"M Skurlova","year":"2024","unstructured":"Skurlova M, Holubova K, Kleteckova L, Kozak T, Kubova H, Horacek J, et al. Chemobrain in blood cancers: how chemotherapeutics interfere with the brain\u2019s structure and functionality, immune system, and metabolic functions. Med Res Rev. 2024;44:5\u201322.","journal-title":"Med Res Rev"},{"key":"902_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","volume":"12","author":"JS Wefel","year":"2012","unstructured":"Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12:267\u201375.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"902_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","volume":"72","author":"XM Wang","year":"2015","unstructured":"Wang XM, Walitt B, Saligan L, Tiwari AFY, Cheung CW, Zhang ZJ, Chemobrain. A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine. 2015;72:86.","journal-title":"Cytokine"},{"key":"902_CR31","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/pon.3086","volume":"22","author":"CM Nguyen","year":"2013","unstructured":"Nguyen CM, Yamada TH, Beglinger LJ, Cavanaugh JE, Denburg NL, Schultz SK. Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions. Psychooncology. 2013;22:862\u20138.","journal-title":"Psychooncology"},{"key":"902_CR32","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","volume":"30","author":"TA Ahles","year":"2012","unstructured":"Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment\u2013associated cognitive change: an update on the state of the science. J Clin Oncol. 2012;30:3675.","journal-title":"J Clin Oncol"},{"key":"902_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-019-03827-0","volume":"84","author":"SE El-Agamy","year":"2019","unstructured":"El-Agamy SE, Abdel-Aziz AK, Esmat A, Azab SS. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemother Pharmacol. 2019;84:1\u201314.","journal-title":"Cancer Chemother Pharmacol"},{"key":"902_CR34","doi-asserted-by":"publisher","first-page":"117085","DOI":"10.1016\/j.taap.2024.117085","volume":"492","author":"M Barbosa-Azevedo","year":"2024","unstructured":"Barbosa-Azevedo M, Dias-Carvalho A, Carvalho F, Costa VM. Chemotherapy-induced cognitive impairment and glia: a new take on chemobrain? Toxicol Appl Pharmacol. 2024;492:117085.","journal-title":"Toxicol Appl Pharmacol"},{"key":"902_CR35","doi-asserted-by":"publisher","first-page":"118071","DOI":"10.1016\/j.lfs.2020.118071","volume":"258","author":"NM Mounier","year":"2020","unstructured":"Mounier NM, Abdel-Maged AES, Wahdan SA, Gad AM, Azab SS. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis. Life Sci. 2020;258:118071.","journal-title":"Life Sci"},{"key":"902_CR36","doi-asserted-by":"publisher","first-page":"152456","DOI":"10.1016\/j.bbrc.2025.152456","volume":"779","author":"S Chughtai","year":"2025","unstructured":"Chughtai S, Doyle D, Tata S, Ram D, Oymagil I. Chemotherapy-induced cognitive impairment: mechanisms, emerging biomarkers, and therapeutic interventions. Biochem Biophys Res Commun. 2025;779:152456.","journal-title":"Biochem Biophys Res Commun"},{"key":"902_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-021-00463-2","volume":"16","author":"LD Nguyen","year":"2021","unstructured":"Nguyen LD, Fischer TT, Ehrlich BE. Pharmacological rescue of cognitive function in a mouse model of chemobrain. Mol Neurodegener. 2021;16:41.","journal-title":"Mol Neurodegener"},{"key":"902_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123842","volume":"12","author":"HR Fernandez","year":"2020","unstructured":"Fernandez HR, Varma A, Flowers SA, Rebeck GW. Cancer chemotherapy related cognitive impairment and the impact of the Alzheimer\u2019s disease risk factor APOE. Cancers (Basel). 2020;12:1\u201325.","journal-title":"Cancers (Basel)"},{"key":"902_CR39","doi-asserted-by":"publisher","first-page":"118581","DOI":"10.1016\/j.biopha.2025.118581","volume":"192","author":"HG Kim","year":"2025","unstructured":"Kim HG, Rashid MA, Poleschuk M, Ullah F, Lee SH, Kim SH, et al. Cognitive dysfunction in chemobrain: molecular mechanisms and therapeutic implications. Biomed Pharmacother. 2025;192:118581.","journal-title":"Biomed Pharmacother"},{"key":"902_CR40","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1002\/cam4.5319","volume":"12","author":"S Yao","year":"2023","unstructured":"Yao S, Li W, Liu S, Cai Y, Zhang Q, Tang L, et al. Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy. Cancer Med. 2023;12:5209\u201321.","journal-title":"Cancer Med"},{"key":"902_CR41","first-page":"532","volume":"31","author":"I Semendric","year":"2023","unstructured":"Semendric I, Pollock D, Haller OJ, George RP, Collins-Praino LE, Whittaker AL. Chemobrain in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review. Support Care Cancer. 2023;31:532.","journal-title":"Support Care Cancer"},{"key":"902_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00204-021-03171-4","volume":"96","author":"A Dias-Carvalho","year":"2021","unstructured":"Dias-Carvalho A, Ferreira M, Ferreira R, Bastos M, de S\u00e1 L, Capela SI. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events. Arch Toxicol. 2021;96:11\u201378.","journal-title":"Arch Toxicol"},{"key":"902_CR43","doi-asserted-by":"publisher","first-page":"e70908","DOI":"10.1002\/cam4.70908","volume":"14","author":"MCC Onyedibe","year":"2025","unstructured":"Onyedibe MCC, Schmidt ME, Bizer P, Zimmer P, Steindorf K. Subjective and objective cancer-related cognitive impairments among systemic and radiation therapy-na\u00efve female cancer patients. Cancer Med. 2025;14:e70908.","journal-title":"Cancer Med"},{"key":"902_CR44","doi-asserted-by":"publisher","first-page":"3942439","DOI":"10.1155\/2020\/3942439","volume":"2020","author":"L Lv","year":"2020","unstructured":"Lv L, Mao S, Dong H, Hu P, Dong R. Pathogenesis, assessments, and management of chemotherapy-related cognitive impairment (CRCI): an updated literature review. J Oncol. 2020;2020:3942439.","journal-title":"J Oncol"},{"key":"902_CR45","doi-asserted-by":"publisher","first-page":"pkz099","DOI":"10.1093\/jncics\/pkz099","volume":"4","author":"K Van Dyk","year":"2020","unstructured":"Van Dyk K, Crespi CM, Petersen L, Ganz PA. Identifying cancer-related cognitive impairment using the FACT-Cog perceived cognitive impairment. JNCI Cancer Spectr. 2020;4:pkz099.","journal-title":"JNCI Cancer Spectr"},{"key":"902_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5498\/wjp.v6.i1.84","volume":"6","author":"M Serra-Mill\u00e0s","year":"2016","unstructured":"Serra-Mill\u00e0s M. Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation? World J Psychiatry. 2016;6:84\u2013101.","journal-title":"World J Psychiatry"},{"key":"902_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fimmu.2020.00249","volume":"11","author":"L Lanser","year":"2020","unstructured":"Lanser L, Kink P, Egger EM, Willenbacher W, Fuchs D, Weiss G, et al. Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer. Front Immunol. 2020;11:249.","journal-title":"Front Immunol"},{"key":"902_CR48","first-page":"1478","volume":"22","author":"D Karati","year":"2021","unstructured":"Karati D, Mahadik KR, Trivedi P, Kumar D. Alkylating agents, the road less traversed, changing anticancer therapy. Anticancer Agents Med Chem. 2021;22:1478\u201395.","journal-title":"Anticancer Agents Med Chem"},{"key":"902_CR49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1517\/13543776.17.9.1061","volume":"17","author":"R Ralhan","year":"2007","unstructured":"Ralhan R, Kaur J. Alkylating agents and cancer therapy. Expert Opin Ther Pat. 2007;17:1061\u201375.","journal-title":"Expert Opin Ther Pat"},{"key":"902_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s43440-020-00109-y","volume":"72","author":"K Sa\u0142at","year":"2020","unstructured":"Sa\u0142at K. Chemotherapy-induced peripheral neuropathy: part 1\u2014current state of knowledge and perspectives for pharmacotherapy. Pharmacol Rep. 2020;72:486.","journal-title":"Pharmacol Rep"},{"key":"902_CR51","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.4103\/jcrt.jcrt_517_24","volume":"20","author":"Y Gao","year":"2024","unstructured":"Gao Y, Wang Y, Lu J, Lian J, Yang L, Liu J, et al. Dynamic changes in brain glymphatic function during preoperative chemotherapy in breast cancer patients. J Cancer Res Ther. 2024;20:1306\u201313.","journal-title":"J Cancer Res Ther"},{"key":"902_CR52","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.3390\/ijms26104838","volume":"26","author":"M Shi","year":"2025","unstructured":"Shi M, Kan H, Tang Y, Tian L, Guo X, Chen W, et al. Icariin ameliorates cyclophosphamide-induced renal encephalopathy by modulating the NF-\u03baB and Keap1-Nrf2 signaling pathways. Int J Mol Sci. 2025;26:4838.","journal-title":"Int J Mol Sci"},{"key":"902_CR53","doi-asserted-by":"publisher","first-page":"114216","DOI":"10.1016\/j.intimp.2025.114216","volume":"149","author":"JS Lopez","year":"2025","unstructured":"Lopez JS, Banerji U. Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: potential crosstalk between gut\u2013brain and NLRP3 inflammasome axes. Int Immunopharmacol. 2025;149:114216.","journal-title":"Int Immunopharmacol"},{"key":"902_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuro.2024.08.003","volume":"105","author":"Z Hussein","year":"2024","unstructured":"Hussein Z, Michel HE, El-Naga RN, El-Demerdash E, Mantawy EM. Coenzyme Q10 ameliorates cyclophosphamide-induced chemobrain by repressing neuronal apoptosis and preserving hippocampal neurogenesis: mechanistic roles of Wnt\/ \u03b2-catenin signaling pathway. Neurotoxicology. 2024;105:21\u201333.","journal-title":"Neurotoxicology"},{"key":"902_CR55","doi-asserted-by":"publisher","first-page":"e0305365","DOI":"10.1371\/journal.pone.0305365","volume":"19","author":"R Botelho","year":"2024","unstructured":"Botelho R, Kirstein CL, Philpot RM. Cyclophosphamide- and doxorubicin-induced impairment of high affinity choline uptake and spatial memory can be prevented by dietary choline supplementation in breast tumor bearing mice. PLoS ONE. 2024;19:e0305365.","journal-title":"PLoS ONE"},{"key":"902_CR56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nlm.2010.01.006","volume":"93","author":"M Yang","year":"2010","unstructured":"Yang M, Kim JS, Song MS, Kim SH, Kang SS, Bae CS, et al. Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol Learn Mem. 2010;93:487\u201394.","journal-title":"Neurobiol Learn Mem"},{"key":"902_CR57","doi-asserted-by":"publisher","first-page":"e21445","DOI":"10.1371\/journal.pone.0021445","volume":"6","author":"L Lyons","year":"2011","unstructured":"Lyons L, ELBeltagy M, Bennett G, Wigmore P. The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat. PLoS ONE. 2011;6:e21445.","journal-title":"PLoS ONE"},{"key":"902_CR58","doi-asserted-by":"publisher","first-page":"265766","DOI":"10.3389\/fncel.2017.00171","volume":"11","author":"L Wu","year":"2017","unstructured":"Wu L, Guo D, Liu Q, Gao F, Wang X, Song X, et al. Abnormal development of dendrites in adult-born rat hippocampal granule cells induced by cyclophosphamide. Front Cell Neurosci. 2017;11:265766.","journal-title":"Front Cell Neurosci"},{"key":"902_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pathophysiology32010011","volume":"32","author":"A Nikolaeva","year":"2025","unstructured":"Nikolaeva A, Pospelova M, Krasnikova V, Makhanova A, Tonyan S, Efimtsev A, et al. MRI voxel morphometry shows brain volume changes in breast cancer survivors: implications for treatment. Pathophysiology. 2025;32:11.","journal-title":"Pathophysiology"},{"key":"902_CR60","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/jnr.25178","volume":"101","author":"J Yang","year":"2023","unstructured":"Yang J, Deng Y, Liu D, Tan Y, Lin M, Zhou X, et al. Brain network deficits in breast cancer patients after early neoadjuvant chemotherapy: a longitudinal MRI study. J Neurosci Res. 2023;101:1138\u201353.","journal-title":"J Neurosci Res"},{"key":"902_CR61","doi-asserted-by":"publisher","first-page":"14298","DOI":"10.1073\/pnas.162491399","volume":"99","author":"S Ishida","year":"2002","unstructured":"Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci U S A. 2002;99:14298\u2013302.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"902_CR62","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1124\/mol.108.052381","volume":"75","author":"CA Larson","year":"2009","unstructured":"Larson CA, Blair BG, Safaei R, Howell SB. The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Mol Pharmacol. 2009;75:324\u201330.","journal-title":"Mol Pharmacol"},{"key":"902_CR63","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1124\/mol.109.063172","volume":"77","author":"SB Howell","year":"2010","unstructured":"Howell SB, Safaei R, Larson CA, Sailor MJ. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol. 2010;77:887\u201394.","journal-title":"Mol Pharmacol"},{"key":"902_CR64","doi-asserted-by":"publisher","first-page":"113118","DOI":"10.1016\/j.expneurol.2019.113118","volume":"324","author":"B Ongnok","year":"2020","unstructured":"Ongnok B, Chattipakorn N, Chattipakorn SC. Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions. Exp Neurol. 2020;324:113118.","journal-title":"Exp Neurol"},{"key":"902_CR65","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s11357-025-01569-x","volume":"47","author":"R Patai","year":"2025","unstructured":"Patai R, Csik B, Nyul-Toth A, Gulej R, Vali Kordestan K, Chandragiri SS, et al. Persisting blood\u2013brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment. GeroScience. 2025;47:3835\u201347.","journal-title":"GeroScience"},{"key":"902_CR66","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/hbm.22942","volume":"36","author":"MM Stouten-Kemperman","year":"2015","unstructured":"Stouten-Kemperman MM, de Ruiter MB, Caan MWA, Boogerd W, Kerst MJ, Reneman L, et al. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Hum Brain Mapp. 2015;36:4638\u201347.","journal-title":"Hum Brain Mapp"},{"key":"902_CR67","doi-asserted-by":"crossref","unstructured":"Amidi A, Hosseini SMH, Leemans A, Kesler SR, Agerb\u00e6k M, Wu LM, et al. Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. J Natl Cancer Inst. 2017;109(12):djx085.","DOI":"10.1093\/jnci\/djx085"},{"key":"902_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/JTO.0000000000000345","volume":"10","author":"M Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 M, Root JC, Vaquero L, Ripoll\u00e9s P, Jov\u00e9 J, Ahles T, et al. Cognitive and brain structural changes in a lung cancer population. J Thorac Oncol. 2015;10:38\u201345.","journal-title":"J Thorac Oncol"},{"key":"902_CR69","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/acn3.121","volume":"1","author":"LL Horky","year":"2014","unstructured":"Horky LL, Gerbaudo VH, Zaitsev A, Plesniak W, Hainer J, Govindarajulu U, et al. Systemic chemotherapy decreases brain glucose metabolism. Ann Clin Transl Neurol. 2014;1:788\u201398.","journal-title":"Ann Clin Transl Neurol"},{"key":"902_CR70","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1021\/acschemneuro.5b00029","volume":"7","author":"SV Kaplan","year":"2016","unstructured":"Kaplan SV, Limbocker RA, Gehringer RC, Divis JL, Osterhaus GL, Newby MD, et al. Impaired brain dopamine and serotonin release and uptake in Wistar rats following treatment with carboplatin. ACS Chem Neurosci. 2016;7:689.","journal-title":"ACS Chem Neurosci"},{"key":"902_CR71","doi-asserted-by":"publisher","first-page":"1027515","DOI":"10.3389\/fonc.2022.1027515","volume":"12","author":"S Liu","year":"2022","unstructured":"Liu S, Ni J, Yan F, Yin N, Li X, Ma R, et al. Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen. Front Oncol. 2022;12:1027515.","journal-title":"Front Oncol"},{"key":"902_CR72","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/cphc.201701357","volume":"19","author":"TM Field","year":"2018","unstructured":"Field TM, Shin M, Stucky CS, Loomis J, Johnson MA. Electrochemical measurement of dopamine release and uptake in zebrafish following treatment with carboplatin. ChemPhysChem. 2018;19:1192.","journal-title":"ChemPhysChem"},{"key":"902_CR73","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbr.2015.04.038","volume":"291","author":"JE Fardell","year":"2015","unstructured":"Fardell JE, Vardy J, Monds LA, Johnston IN. The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy. Behav Brain Res. 2015;291:80\u20138.","journal-title":"Behav Brain Res"},{"key":"902_CR74","doi-asserted-by":"publisher","first-page":"1431579","DOI":"10.3389\/fphar.2024.1431579","volume":"15","author":"X Pan","year":"2024","unstructured":"Pan X, Xiao X, Ding Y, Shu Y, Zhang W, Huang L. Neurological adverse events associated with oxaliplatin: a pharmacovigilance analysis based on FDA adverse event reporting system. Front Pharmacol. 2024;15:1431579.","journal-title":"Front Pharmacol"},{"key":"902_CR75","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/WCO.0b013e3282f1a06e","volume":"20","author":"G Kannarkat","year":"2007","unstructured":"Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007;20:719\u201325.","journal-title":"Curr Opin Neurol"},{"key":"902_CR76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bcpt.12629","volume":"120","author":"E Bianchi","year":"2017","unstructured":"Bianchi E, Di Cesare Mannelli L, Micheli L, Farzad M, Aglian\u00f2 M, Ghelardini C. Apoptotic process induced by oxaliplatin in rat hippocampus causes memory impairment. Basic Clin Pharmacol Toxicol. 2017;120:14\u201321.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"902_CR77","doi-asserted-by":"publisher","first-page":"23426","DOI":"10.18632\/oncotarget.25193","volume":"9","author":"JJV Branca","year":"2018","unstructured":"Branca JJV, Maresca M, Morucci G, Becatti M, Paternostro F, Gulisano M, et al. Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity. Oncotarget. 2018;9:23426\u201338.","journal-title":"Oncotarget"},{"key":"902_CR78","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/NRL.0000000000000105","volume":"21","author":"J How","year":"2016","unstructured":"How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE. Chemotherapy-associated posterior reversible encephalopathy syndrome: a case report and review of the literature. Neurologist. 2016;21:112.","journal-title":"Neurologist"},{"key":"902_CR79","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1200\/JCO.2007.13.5954","volume":"25","author":"DM Pinedo","year":"2007","unstructured":"Pinedo DM, Shah-Khan F, Shah PC. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin. J Clin Oncol. 2007;25:5320\u20131.","journal-title":"J Clin Oncol"},{"key":"902_CR80","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00415-006-0273-1","volume":"254","author":"G Mor\u00eds","year":"2007","unstructured":"Mor\u00eds G, Ribacoba R, Gonz\u00e1lez C. Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine. J Neurol. 2007;254:534\u20135.","journal-title":"J Neurol"},{"key":"902_CR81","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","volume":"27","author":"LE Ta","year":"2006","unstructured":"Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology. 2006;27:992\u20131002.","journal-title":"Neurotoxicology"},{"key":"902_CR82","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1038\/sj.onc.1208047","volume":"23","author":"I Gourdier","year":"2004","unstructured":"Gourdier I, Crabbe L, Andreau K, Pau B, Kroemer G. Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA. Oncogene. 2004;23:7449\u201357.","journal-title":"Oncogene"},{"key":"902_CR83","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/antiox10071116","volume":"10","author":"O Cauli","year":"2021","unstructured":"Cauli O. Oxidative stress and cognitive alterations induced by cancer chemotherapy drugs: a scoping review. Antioxidants. 2021;10:1116.","journal-title":"Antioxidants"},{"key":"902_CR84","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1021\/acs.analchem.5c07278","volume":"98","author":"J Chen","year":"2026","unstructured":"Chen J, Liu Y, Cao L, Zhou J, Nan X, Li C, et al. Investigating the effect of oxaliplatin on vesicular dopamine cargo and release dynamics in brain with single-vesicle electrochemistry. Anal Chem. 2026;98:3307\u201315.","journal-title":"Anal Chem"},{"key":"902_CR85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5603\/FM.a2020.0031","volume":"80","author":"J Sadeghinezhad","year":"2021","unstructured":"Sadeghinezhad J, Amrein I. Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin. Folia Morphol (Warsz). 2021;80:26\u201332.","journal-title":"Folia Morphol (Warsz)"},{"key":"902_CR86","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40264-022-01182-3","volume":"45","author":"GR Onzi","year":"2022","unstructured":"Onzi GR, D\u2019Agustini N, Garcia SC, Guterres SS, Pohlmann PR, Rosa DD, et al. Chemobrain in breast cancer: mechanisms, clinical manifestations, and potential interventions. Drug Saf. 2022;45:601\u201321.","journal-title":"Drug Saf"},{"key":"902_CR87","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1039\/D1FO03055H","volume":"12","author":"A Abulizi","year":"2021","unstructured":"Abulizi A, Ran J, Ye Y, An Y, Zhang Y, Huang Z, et al. Ganoderic acid improves 5-fluorouracil-induced cognitive dysfunction in mice. Food Funct. 2021;12:12325\u201337.","journal-title":"Food Funct"},{"key":"902_CR88","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1093\/oncolo\/oyae090","volume":"29","author":"G Oliva","year":"2024","unstructured":"Oliva G, Giustiniani A, Danesin L, Burgio F, Arcara G, Conte P. Cognitive impairment following breast cancer treatments: an umbrella review. Oncologist. 2024;29:e848.","journal-title":"Oncologist"},{"key":"902_CR89","first-page":"11","volume":"7","author":"P Huehnchen","year":"2019","unstructured":"Huehnchen P, Van Kampen A, Boehmerle W, Endres M. Cognitive impairment after cytotoxic chemotherapy. Neurooncol Pract. 2019;7:11.","journal-title":"Neurooncol Pract"},{"key":"902_CR90","doi-asserted-by":"publisher","first-page":"10074","DOI":"10.3390\/ijms262010074","volume":"26","author":"YT Fierro-Salgado","year":"2025","unstructured":"Fierro-Salgado YT, Reiriz M, Beltr\u00e1n-Velasco AI, Calleja-Conde J, Hern\u00e1ndez-O\u00f1ativia X, Uceda S, et al. Cytokines and brain-derived neurotrophic factor as biomarkers of cognitive impairment related to breast cancer and its treatments: a systematic review. Int J Mol Sci. 2025;26:10074.","journal-title":"Int J Mol Sci"},{"key":"902_CR91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbi.2013.11.003","volume":"37","author":"KB Weymann","year":"2013","unstructured":"Weymann KB, Wood LJ, Zhu X, Marks DL. A Role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun. 2013;37:84.","journal-title":"Brain Behav Immun"},{"key":"902_CR92","doi-asserted-by":"publisher","first-page":"115245","DOI":"10.1016\/j.biopha.2023.115245","volume":"165","author":"LI Alotayk","year":"2023","unstructured":"Alotayk LI, Aldubayan MA, Alenezi SK, Anwar MJ, Alhowail AH. Comparative evaluation of doxorubicin, cyclophosphamide, 5-fluorouracil, and cisplatin on cognitive dysfunction in rats: Delineating the role of inflammation of hippocampal neurons and hypothyroidism. Biomed Pharmacother. 2023;165:115245.","journal-title":"Biomed Pharmacother"},{"key":"902_CR93","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/jbiol69","volume":"7","author":"R Han","year":"2008","unstructured":"Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pr\u00f6schel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol. 2008;7:12.","journal-title":"J Biol"},{"key":"902_CR94","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbr.2014.12.028","volume":"281","author":"G Winocur","year":"2015","unstructured":"Winocur G, Wojtowicz JM, Tannock IF. Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis. Behav Brain Res. 2015;281:239\u201344.","journal-title":"Behav Brain Res"},{"key":"902_CR95","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1460-9568.2008.06325.x","volume":"28","author":"S Mustafa","year":"2008","unstructured":"Mustafa S, Walker A, Bennett G, Wigmore PM. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci. 2008;28:323\u201330.","journal-title":"Eur J Neurosci"},{"key":"902_CR96","doi-asserted-by":"publisher","first-page":"26903","DOI":"10.31083\/JIN26903","volume":"24","author":"X Huang","year":"2025","unstructured":"Huang X, Peng S, Lan Y, Chen W, Wu J, Huang X, et al. 5-Fluorouracil impairs transmission of acetylcholine in the hippocampus and induces cognitive impairments in mice. J Integr Neurosci. 2025;24:26903.","journal-title":"J Integr Neurosci"},{"key":"902_CR97","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.3390\/molecules27196229","volume":"27","author":"IS Kovalev","year":"2022","unstructured":"Kovalev IS, Zyryanov GV, Santra S, Majee A, Varaksin MV, Charushin VN. Folic acid antimetabolites (antifolates): a brief review on synthetic strategies and application opportunities. Molecules. 2022;27:6229.","journal-title":"Molecules"},{"key":"902_CR98","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","volume":"32","author":"D Bhojwani","year":"2014","unstructured":"Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014;32:949.","journal-title":"J Clin Oncol"},{"key":"902_CR99","doi-asserted-by":"publisher","first-page":"123514","DOI":"10.1016\/j.jns.2025.123514","volume":"473","author":"S Besora","year":"2025","unstructured":"Besora S, Garcilazo-Reyes Y, Velasco R. Methotrexate-induced neurotoxicity in oncology: current issues for a classic drug. J Neurol Sci. 2025;473:123514.","journal-title":"J Neurol Sci"},{"key":"902_CR100","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41390-024-03351-9","volume":"97","author":"R Bansal","year":"2024","unstructured":"Bansal R, Bhojwani D, Sun BF, Sawardekar S, Wayne AS, Ouassil H, et al. Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemia. Pediatr Res. 2024;97:348.","journal-title":"Pediatr Res"},{"key":"902_CR101","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11682-010-9104-1","volume":"4","author":"SR Kesler","year":"2010","unstructured":"Kesler SR, Tanaka H, Koovakkattu D. Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia. Brain Imaging Behav. 2010;4:256.","journal-title":"Brain Imaging Behav"},{"key":"902_CR102","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/pbc.24947","volume":"61","author":"WE Reddick","year":"2014","unstructured":"Reddick WE, Taghipour DJ, Glass JO, Ashford J, Xiong X, Wu S, et al. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers. Pediatr Blood Cancer. 2014;61:1074.","journal-title":"Pediatr Blood Cancer"},{"key":"902_CR103","doi-asserted-by":"publisher","first-page":"e78599","DOI":"10.1371\/journal.pone.0078599","volume":"8","author":"M Genschaft","year":"2013","unstructured":"Genschaft M, Huebner T, Plessow F, Ikonomidou VN, Abolmaali N, Krone F, et al. Impact of chemotherapy for childhood leukemia on brain morphology and function. PLoS ONE. 2013;8:e78599.","journal-title":"PLoS ONE"},{"key":"902_CR104","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00234-016-1777-8","volume":"59","author":"O Zaj\u0105c-Spycha\u0142a","year":"2017","unstructured":"Zaj\u0105c-Spycha\u0142a O, Pawlak MA, Karmelita-Katulska K, Pilarczyk J, Derwich K, Wachowiak J. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy. Neuroradiology. 2017;59:147.","journal-title":"Neuroradiology"},{"key":"902_CR105","doi-asserted-by":"publisher","first-page":"pkab069","DOI":"10.1093\/jncics\/pkab069","volume":"5","author":"K Gandy","year":"2021","unstructured":"Gandy K, Scoggins MA, Jacola LM, Litten M, Reddick WE, Krull KR. Structural and functional brain imaging in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy: a systematic review. JNCI Cancer Spectr. 2021;5:pkab069.","journal-title":"JNCI Cancer Spectr"},{"key":"902_CR106","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/biomedicines12040908","volume":"12","author":"YC Chen","year":"2024","unstructured":"Chen YC, Hou CY, Hsu MH, Huang LT, Hsiao CC, Sheen JM. the impact of gut microbiota changes on methotrexate-induced neurotoxicity in developing young rats. Biomedicines. 2024;12:908.","journal-title":"Biomedicines"},{"key":"902_CR107","doi-asserted-by":"publisher","first-page":"1212791","DOI":"10.3389\/fnins.2023.1212791","volume":"17","author":"C Corley","year":"2023","unstructured":"Corley C, McElroy T, Sridharan B, Trujillo M, Simmons P, Kandel S, et al. Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior. Front Neurosci. 2023;17:1212791.","journal-title":"Front Neurosci"},{"key":"902_CR108","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1007\/s11357-025-01560-6","volume":"47","author":"B Csik","year":"2025","unstructured":"Csik B, Vali Kordestan K, Gulej R, Patai R, Nyul-Toth A, Shanmugarama S, et al. Cisplatin and methotrexate induce brain microvascular endothelial and microglial senescence in mouse models of chemotherapy-associated cognitive impairment. Geroscience. 2025;47:3447.","journal-title":"Geroscience"},{"key":"902_CR109","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuroscience.2019.01.024","volume":"404","author":"I Elens","year":"2019","unstructured":"Elens I, Dekeyster E, Moons L, D\u2019Hooge R. Methotrexate affects cerebrospinal fluid folate and tau levels and induces late cognitive deficits in mice. Neuroscience. 2019;404:62\u201370.","journal-title":"Neuroscience"},{"key":"902_CR110","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","volume":"10","author":"S Rivankar","year":"2014","unstructured":"Rivankar S. An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther. 2014;10:853\u20138.","journal-title":"J Cancer Res Ther"},{"key":"902_CR111","doi-asserted-by":"publisher","first-page":"173078","DOI":"10.1016\/j.ejphar.2020.173078","volume":"881","author":"S Eide","year":"2020","unstructured":"Eide S, Feng ZP. Doxorubicin chemotherapy-induced chemo-brain: Meta-analysis. Eur J Pharmacol. 2020;881:173078.","journal-title":"Eur J Pharmacol"},{"key":"902_CR112","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.3390\/ijms26104736","volume":"26","author":"KS Bhatt","year":"2025","unstructured":"Bhatt KS, Singh A, Marwaha GS, Ravendranathan N, Sandhu IS, Kim K, et al. Different mechanisms in doxorubicin-induced neurotoxicity: impact of BRCA mutations. Int J Mol Sci. 2025;26:4736.","journal-title":"Int J Mol Sci"},{"key":"902_CR113","doi-asserted-by":"publisher","first-page":"8497","DOI":"10.1007\/s00210-024-03766-5","volume":"398","author":"KJ Garcia","year":"2025","unstructured":"Garcia KJ, Theismann JT, Schneider TD, LeComte RS, Jarmolowicz DP, Johnson MA. Doxorubicin treatment has a biphasic effect over time on dopamine release and impulsive behavior in Wistar rats. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:8497\u2013509.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"902_CR114","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2017.07.003","volume":"1672","author":"TC Thomas","year":"2017","unstructured":"Thomas TC, Beitchman JA, Pomerleau F, Noel T, Jungsuwadee P, Allan Butterfield D, et al. Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain Res. 2017;1672:10\u20137.","journal-title":"Brain Res"},{"key":"902_CR115","doi-asserted-by":"publisher","first-page":"8831","DOI":"10.1007\/s12035-024-04145-0","volume":"61","author":"B Ongnok","year":"2024","unstructured":"Ongnok B, Prathumsap N, Chunchai T, Pantiya P, Arunsak B, Chattipakorn N, et al. Nicotinic and muscarinic acetylcholine receptor agonists counteract cognitive impairment in a rat model of doxorubicin-induced chemobrain via attenuation of multiple programmed cell death pathways. Mol Neurobiol. 2024;61:8831\u201350.","journal-title":"Mol Neurobiol"},{"key":"902_CR116","doi-asserted-by":"publisher","first-page":"103355","DOI":"10.1016\/j.neuro.2025.103355","volume":"111","author":"C Patel","year":"2025","unstructured":"Patel C, Glytsou C, Jang MH, Cole PD. The effects of doxorubicin on blood-brain barrier integrity in hCMEC\/D3. Neurotoxicology. 2025;111:103355.","journal-title":"Neurotoxicology"},{"key":"902_CR117","first-page":"205","volume":"44","author":"FY Alqahtani","year":"2019","unstructured":"Alqahtani FY, Aleanizy FS, El Tahir E, Alkahtani HM, AlQuadeib BT. Paclitaxel Profiles Drug Subst Excip Relat Methodol. 2019;44:205\u201338.","journal-title":"Paclitaxel Profiles Drug Subst Excip Relat Methodol"},{"key":"902_CR118","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10495-022-01750-z","volume":"27","author":"S Zhao","year":"2022","unstructured":"Zhao S, Tang Y, Wang R, Najafi M. Mechanisms of cancer cell death induction by paclitaxel: an updated review. Apoptosis. 2022;27:647\u201367.","journal-title":"Apoptosis"},{"key":"902_CR119","doi-asserted-by":"publisher","first-page":"1684006","DOI":"10.3389\/fphar.2025.1684006","volume":"16","author":"AH Alhowail","year":"2025","unstructured":"Alhowail AH. Paclitaxel-induced cognitive impairment: mechanistic insights. Front Pharmacol. 2025;16:1684006.","journal-title":"Front Pharmacol"},{"key":"902_CR120","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1080\/13880209.2022.2108064","volume":"60","author":"M Tang","year":"2022","unstructured":"Tang M, Zhao S, Liu JX, Liu X, Guo YX, Wang GY, et al. Paclitaxel induces cognitive impairment via necroptosis, decreased synaptic plasticity and M1 polarisation of microglia. Pharm Biol. 2022;60:1556.","journal-title":"Pharm Biol"},{"key":"902_CR121","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/oncolo\/oyae268","volume":"30","author":"A Kerkmann","year":"2025","unstructured":"Kerkmann A, Schinke C, Dordevic A, Kern J, Bangemann N, Finck J, et al. Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study. Oncologist. 2025;30:268.","journal-title":"Oncologist"},{"key":"902_CR122","doi-asserted-by":"publisher","first-page":"3941840","DOI":"10.1155\/2018\/3941840","volume":"2018","author":"Z Li","year":"2018","unstructured":"Li Z, Zhao S, Zhang HL, Liu P, Liu FF, Guo YX, et al. Proinflammatory factors mediate paclitaxel-induced impairment of learning and memory. Mediators Inflamm. 2018;2018:3941840.","journal-title":"Mediators Inflamm"},{"key":"902_CR123","doi-asserted-by":"publisher","first-page":"e13832","DOI":"10.1111\/acel.13832","volume":"22","author":"C Ahire","year":"2023","unstructured":"Ahire C, Nyul-Toth A, DelFavero J, Gulej R, Faakye JA, Tarantini S, et al. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain. Aging Cell. 2023;22:e13832.","journal-title":"Aging Cell"},{"key":"902_CR124","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1007\/s11357-025-01624-7","volume":"47","author":"SS Chandragiri","year":"2025","unstructured":"Chandragiri SS, Nyul-Toth A, Negri S, Patai R, Gulej R, Csik B, et al. Functional ultrasound imaging reveals microvascular rarefaction, decreased cerebral blood flow, and impaired neurovascular coupling in a mouse model of paclitaxel-induced chemobrain. Geroscience. 2025;47:4813.","journal-title":"Geroscience"},{"key":"902_CR125","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1007\/s11357-025-01561-5","volume":"47","author":"R Patai","year":"2025","unstructured":"Patai R, Kiss T, Gulej R, Nyul-Toth A, Csik B, Chandragiri SS, et al. Transcriptomic profiling of senescence effects on blood\u2013brain barrier-related gene expression in brain capillary endothelial cells in a mouse model of paclitaxel-induced chemobrain. Geroscience. 2025;47:3677\u201391.","journal-title":"Geroscience"},{"key":"902_CR126","doi-asserted-by":"publisher","first-page":"pkad022","DOI":"10.1093\/jncics\/pkad022","volume":"7","author":"PR Lee Meeuw Kjoe","year":"2023","unstructured":"Lee Meeuw Kjoe PR, Kieffer JM, Small BJ, Boogerd W, Schilder CM, van der Wall E, et al. Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer. JNCI Cancer Spectr. 2023;7:pkad022.","journal-title":"JNCI Cancer Spectr"},{"key":"902_CR127","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1200\/JCO.2008.21.3553","volume":"28","author":"CM Schilder","year":"2010","unstructured":"Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol. 2010;28:1294\u2013300.","journal-title":"J Clin Oncol"},{"key":"902_CR128","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/GME.0000000000000271","volume":"22","author":"FW Boele","year":"2015","unstructured":"Boele FW, Schilder CMT, De Roode M, Lou, Deijen JB, Schagen SB. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause. 2015;22:17\u201325.","journal-title":"Menopause"},{"key":"902_CR129","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.clbc.2013.10.010","volume":"14","author":"A Hurria","year":"2013","unstructured":"Hurria A, Patel SK, Mortimer J, Luu T, Somlo G, Katheria V, et al. The Effect of aromatase inhibition on the cognitive function of older patients with breast cancer. Clin Breast Cancer. 2013;14:132.","journal-title":"Clin Breast Cancer"},{"key":"902_CR130","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2015.124","volume":"12","author":"W Zwart","year":"2015","unstructured":"Zwart W, Terra H, Linn SC, Schagen SB. Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on? Nat Rev Clin Oncol. 2015;12:597\u2013606.","journal-title":"Nat Rev Clin Oncol"},{"key":"902_CR131","doi-asserted-by":"publisher","first-page":"e2114694","DOI":"10.1001\/jamanetworkopen.2021.14694","volume":"4","author":"SMH Alibhai","year":"2021","unstructured":"Alibhai SMH, Breunis H, Feng G, Timilshina N, Hansen A, Warde P, et al. Association of chemotherapy, enzalutamide, abiraterone, and radium 223 with cognitive function in older men with metastatic castration-resistant prostate cancer. JAMA Netw Open. 2021;4:e2114694.","journal-title":"JAMA Netw Open"},{"key":"902_CR132","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/cncr.35210","volume":"130","author":"A Bou\u00e9","year":"2024","unstructured":"Bou\u00e9 A, Joly F, Lequesne J, Lange M. Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis. Cancer. 2024;130:2120\u201338.","journal-title":"Cancer"},{"key":"902_CR133","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/JU.0000000000001341","volume":"205","author":"R Sari Motlagh","year":"2021","unstructured":"Sari Motlagh R, Quhal F, Mori K, Miura N, Aydh A, Laukhtina E, et al. The risk of new onset dementia and\/or Alzheimer disease among patients with prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis. J Urol. 2021;205:60\u20137.","journal-title":"J Urol"},{"key":"902_CR134","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/10428194.2022.2148208","volume":"64","author":"KA Hyland","year":"2023","unstructured":"Hyland KA, Eisel SL, Hoogland AI, Root JC, Bowles K, James B, et al. Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison. Leuk Lymphoma. 2023;64:415\u201323.","journal-title":"Leuk Lymphoma"},{"key":"902_CR135","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jgo.2021.12.012","volume":"13","author":"SM Miller","year":"2022","unstructured":"Miller SM, Wilson LE, Greiner MA, Pritchard JE, Zhang T, Kaye DR, et al. Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma. J Geriatr Oncol. 2022;13:635\u201343.","journal-title":"J Geriatr Oncol"},{"key":"902_CR136","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1002\/cncr.34469","volume":"128","author":"RJ Ferguson","year":"2022","unstructured":"Ferguson RJ, Manculich J, Chang H, Sareen NJ, Snitz BE, Terhorst L, et al. Self-reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: results of a multinational survey. Cancer. 2022;128:4017\u201326.","journal-title":"Cancer"},{"key":"902_CR137","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.expneurol.2016.06.004","volume":"283","author":"AK Abdel-Aziz","year":"2016","unstructured":"Abdel-Aziz AK, Mantawy EM, Said RS, Helwa R. The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries. Exp Neurol. 2016;283:129\u201341.","journal-title":"Exp Neurol"},{"key":"902_CR138","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/pon.4725","volume":"27","author":"S Cuzzubbo","year":"2018","unstructured":"Cuzzubbo S, Belin C, Chouahnia K, Baroudjian B, Duchemann B, Barlog C, et al. Assessing cognitive function in patients treated with immune checkpoint inhibitors: a feasibility study. Psychooncology. 2018;27:1861\u20134.","journal-title":"Psychooncology"},{"key":"902_CR139","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1186\/s12885-022-10384-y","volume":"22","author":"M Lange","year":"2022","unstructured":"Lange M, Clarisse B, Leconte A, Demb\u00e9l\u00e9 KP, Lequesne J, Nicola C, et al. Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial. BMC Cancer. 2022;22:1308.","journal-title":"BMC Cancer"},{"key":"902_CR140","first-page":"523","volume":"33","author":"M Sayer","year":"2025","unstructured":"Sayer M, Agrawal P, Ng DQ, Kagramanov D, Trudeau J, Othy S, et al. Incidence and predictors of immune checkpoint inhibitor treatment-related cognitive impairment in a racial and ethnic diverse population. Support Care Cancer. 2025;33:523.","journal-title":"Support Care Cancer"},{"key":"902_CR141","doi-asserted-by":"publisher","first-page":"1540442","DOI":"10.3389\/fimmu.2025.1540442","volume":"16","author":"G Jian","year":"2025","unstructured":"Jian G, Zeng J, Lu J, Wang W, Jiang Y, Huang T, et al. Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients. Front Immunol. 2025;16:1540442.","journal-title":"Front Immunol"},{"key":"902_CR142","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s43440-020-00106-1","volume":"72","author":"K Sa\u0142at","year":"2020","unstructured":"Sa\u0142at K. Chemotherapy-induced peripheral neuropathy - part 2: focus on the prevention of oxaliplatin-induced neurotoxicity. Pharmacol Rep. 2020;72:508\u201327.","journal-title":"Pharmacol Rep"},{"key":"902_CR143","doi-asserted-by":"publisher","first-page":"102899","DOI":"10.1016\/j.ctrv.2025.102899","volume":"134","author":"G Arrivi","year":"2025","unstructured":"Arrivi G, Fazio N, Tafuto S, Falconi M, Carnaghi C, Campana D, et al. The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms - a systematic review. Cancer Treat Rev. 2025;134:102899.","journal-title":"Cancer Treat Rev"},{"key":"902_CR144","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1159\/000524988","volume":"112","author":"J Capdevila","year":"2022","unstructured":"Capdevila J, Ducreux M, Garc\u00eda Carbonero R, Grande E, Halfdanarson T, Pavel M, et al. Streptozotocin, 1982\u20132022: forty years from the FDA\u2019s approval to treat pancreatic neuroendocrine tumors. Neuroendocrinology. 2022;112:1155\u201367.","journal-title":"Neuroendocrinology"},{"key":"902_CR145","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/xen.12266","volume":"23","author":"JM Kim","year":"2016","unstructured":"Kim JM, Shin JS, Min BH, Kim HJ, Kim JS, Yoon IH, et al. Induction, management, and complications of streptozotocin-induced diabetes mellitus in rhesus monkeys. Xenotransplantation. 2016;23:472\u20138.","journal-title":"Xenotransplantation"},{"key":"902_CR146","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.jchemneu.2022.102207","volume":"127","author":"C Deng","year":"2023","unstructured":"Deng C, Meng Z, Chen H, Meng S. Tetramethylpyrazine ameliorates systemic streptozotocin-induced Alzheimer-like pathology. J Chem Neuroanat. 2023;127:102207.","journal-title":"J Chem Neuroanat"},{"key":"902_CR147","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00702-025-02891-6","volume":"132","author":"E Gr\u00fcnblatt","year":"2025","unstructured":"Gr\u00fcnblatt E, Yde Ohki CM, Schmitt-B\u00f6hrer GA, Riederer P, Walitza S. Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models. J Neural Transm. 2025;132:1479.","journal-title":"J Neural Transm"},{"key":"902_CR148","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1021\/acschemneuro.1c00063","volume":"12","author":"Z Cockova","year":"2021","unstructured":"Cockova Z, Honc O, Telensky P, Olsen MJ, Novotny J. Streptozotocin-induced astrocyte mitochondrial dysfunction is ameliorated by FTO inhibitor MO-I-500. ACS Chem Neurosci. 2021;12:3818\u201328.","journal-title":"ACS Chem Neurosci"},{"key":"902_CR149","doi-asserted-by":"publisher","first-page":"123759","DOI":"10.1016\/j.lfs.2025.123759","volume":"376","author":"Z Tang","year":"2025","unstructured":"Tang Z, Sha T, Wang Y, Xiao Y, Ding Y, Ni R, et al. Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer\u2019s disease. Life Sci. 2025;376:123759.","journal-title":"Life Sci"},{"key":"902_CR150","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1007\/s12035-015-9384-y","volume":"53","author":"PK Kamat","year":"2015","unstructured":"Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS. streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic intervention for treatment of sporadic Alzheimer\u2019s disease (sad)-like pathology. Mol Neurobiol. 2015;53:4548\u201345462.","journal-title":"Mol Neurobiol"},{"key":"902_CR151","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12035-025-05652-4","volume":"63","author":"P Tripathi","year":"2026","unstructured":"Tripathi P, Shah J. Valacyclovir mitigates amyloid plaque deposition, p-tau aggregation, and neuroinflammation in streptozotocin induced Alzheimer\u2019s disease rat model. Mol Neurobiol. 2026;63:356.","journal-title":"Mol Neurobiol"},{"key":"902_CR152","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/cells14211745","volume":"14","author":"SA Habib","year":"2025","unstructured":"Habib SA, Kamal MM, Aly MH, Ghaiad HR, Rizk SM, Banks WA, et al. Streptozotocin causes blood\u2013brain barrier and astrocytic dysfunction in vitro. Cells. 2025;14:1745.","journal-title":"Cells"},{"key":"902_CR153","first-page":"575","volume":"9","author":"M Sabalic","year":"2024","unstructured":"Sabalic M. Antimetabolites in cancer treatment: targeting cellular proliferation pathways. J Can Sci Res. 2024;9:575.","journal-title":"J Can Sci Res"},{"key":"902_CR154","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbadis.2019.02.007","volume":"1865","author":"X Ren","year":"2019","unstructured":"Ren X, Boriero D, Chaiswing L, Bondada S, St. Clair DK, Butterfield DA. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (chemobrain), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1088.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"902_CR155","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbr.2019.01.007","volume":"362","author":"DP Jarmolowicz","year":"2019","unstructured":"Jarmolowicz DP, Gehringer R, Lemley SM, Sofis MJ, Kaplan S, Johnson MA. 5-Fluorouracil impairs attention and dopamine release in rats. Behav Brain Res. 2019;362:319\u201322.","journal-title":"Behav Brain Res"},{"key":"902_CR156","doi-asserted-by":"publisher","first-page":"103365","DOI":"10.1016\/j.neuro.2025.103365","volume":"112","author":"RA Aziz","year":"2026","unstructured":"Aziz RA, Venugopal DM, Kudva AK, Hanumanthappa R, Mustak MS, Devaraju KS, et al. Chemotherapy-induced cognitive impairment (CICI): cisplatin\u2019s effects on neurotransmitter regulation and oxidative stress in Drosophila melanogaster. Neurotoxicology. 2026;112:103365.","journal-title":"Neurotoxicology"},{"key":"902_CR157","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12149-019-01331-2","volume":"33","author":"T Vitor","year":"2019","unstructured":"Vitor T, Kozasa EH, Bressan RA, Lacerda SS, Campos Neto GC, Batista IR, et al. Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1. Ann Nucl Med. 2019;33:269\u201379.","journal-title":"Ann Nucl Med"},{"key":"902_CR158","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0079-6123(07)00008-8","volume":"169","author":"JG Howland","year":"2008","unstructured":"Howland JG, Wang YT. Chapter 8 Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog Brain Res. 2008;169:145\u201358.","journal-title":"Prog Brain Res"},{"key":"902_CR159","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/1099800420938141","volume":"22","author":"H Li","year":"2020","unstructured":"Li H, Liu T, Heinsberg LW, Lockwood MB, Wainwright DA, Jang MK, et al. Systematic review of the kynurenine pathway and psychoneurological symptoms among adult cancer survivors. Biol Res Nurs. 2020;22:472\u201384.","journal-title":"Biol Res Nurs"},{"key":"902_CR160","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/10998004211069619","volume":"24","author":"J Bai","year":"2022","unstructured":"Bai J, Withycombe J, Eldridge RC. Metabolic pathways associated with psychoneurological symptoms in children with cancer receiving chemotherapy. Biol Res Nurs. 2022;24:281\u201393.","journal-title":"Biol Res Nurs"},{"key":"902_CR161","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","volume":"220","author":"B Lu","year":"2014","unstructured":"Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223\u201350.","journal-title":"Handb Exp Pharmacol"},{"key":"902_CR162","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuron.2010.03.035","volume":"66","author":"B Fritsch","year":"2010","unstructured":"Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG, et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: Potential implications for motor learning. Neuron. 2010;66:198\u2013204.","journal-title":"Neuron"},{"key":"902_CR163","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000358824","volume":"36","author":"I Dincheva","year":"2014","unstructured":"Dincheva I, Pattwell SS, Tessarollo L, Bath KG, Lee FS. BDNF modulates contextual fear learning during adolescence. Dev Neurosci. 2014;36:269\u201376.","journal-title":"Dev Neurosci"},{"key":"902_CR164","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1186\/s12885-025-14430-3","volume":"25","author":"J Trudeau","year":"2025","unstructured":"Trudeau J, Ng DQ, Sayer M, Tan CJ, Ke Y, Chan RJ, et al. Brain-derived neurotrophic factor and cytokines as predictors of cognitive impairment in adolescent and young adult cancer patients receiving chemotherapy: a longitudinal study. BMC Cancer. 2025;25:1045.","journal-title":"BMC Cancer"},{"key":"902_CR165","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/febs.16151","volume":"289","author":"R Muraleedharan","year":"2022","unstructured":"Muraleedharan R, Dasgupta B. AMPK in the brain: its roles in glucose and neural metabolism. FEBS J. 2022;289:2247\u201362.","journal-title":"FEBS J"},{"key":"902_CR166","doi-asserted-by":"publisher","first-page":"110945","DOI":"10.1016\/j.intimp.2023.110945","volume":"124","author":"RS Raafat","year":"2023","unstructured":"Raafat RS, Habib MZ, AbdElfattah AA, Olama NK, Abdelraouf SM, Hendawy N, et al. Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling in Wistar rats. Int Immunopharmacol. 2023;124:110945.","journal-title":"Int Immunopharmacol"},{"key":"902_CR167","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.3390\/ijms21165624","volume":"21","author":"C Falcicchia","year":"2020","unstructured":"Falcicchia C, Tozzi F, Arancio O, Watterson DM, Origlia N. Involvement of p38 MAPK in synaptic function and dysfunction. Int J Mol Sci. 2020;21:5624.","journal-title":"Int J Mol Sci"},{"key":"902_CR168","doi-asserted-by":"publisher","first-page":"17378","DOI":"10.1021\/acs.jmedchem.5c00933","volume":"68","author":"S Ferjan\u010di\u010d Benetik","year":"2025","unstructured":"Ferjan\u010di\u010d Benetik S, Proj M, Knez D, Ko\u0161ak U, Meden A, Kraj\u0161ek K, et al. Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38\u03b1 Mitogen-Activated Protein Kinase Inhibitors. J Med Chem. 2025;68:17378\u2013411.","journal-title":"J Med Chem"},{"key":"902_CR169","doi-asserted-by":"publisher","first-page":"108998","DOI":"10.1016\/j.bioorg.2025.108998","volume":"165","author":"SF Benetik","year":"2025","unstructured":"Benetik SF, Meden A, Knez D, Mastnak-Sokolov P, Ko\u0161ak U, Horvat S, et al. Transforming ureas into carbamates: From allosteric p38\u03b1 MAPK ligands to dual BChE\/p38\u03b1 MAPK inhibitors. Bioorg Chem. 2025;165:108998.","journal-title":"Bioorg Chem"},{"key":"902_CR170","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s12265-024-10525-7","volume":"17","author":"X Shi","year":"2024","unstructured":"Shi X, Cao Y, Wang H, Zhao Q, Yan C, Li S, et al. Vaccarin ameliorates doxorubicin-induced cardiotoxicity via inhibition of p38 mapk mediated mitochondrial dysfunction. J Cardiovasc Transl Res. 2024;17:1155\u201371.","journal-title":"J Cardiovasc Transl Res"},{"key":"902_CR171","doi-asserted-by":"publisher","first-page":"178180","DOI":"10.1016\/j.ejphar.2025.178180","volume":"1006","author":"Y Xie","year":"2025","unstructured":"Xie Y, Shen A, Lin H, Zheng H, Lin G, Chen Y, et al. Tetramethylpyrazine ameliorates 5-fluorouracil-Induced cardiotoxicity by inhibiting PANoptosis and suppressing the p38 MAPK\/JNK\/ERK signaling pathway. Eur J Pharmacol. 2025;1006:178180.","journal-title":"Eur J Pharmacol"},{"key":"902_CR172","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tox.2008.11.016","volume":"256","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Song M, Ryu JC. Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009;256:183\u201390.","journal-title":"Toxicology"},{"key":"902_CR173","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12272-023-01436-3","volume":"46","author":"EHM Hassanein","year":"2023","unstructured":"Hassanein EHM, Sayed AM, El-Ghafar OAMA, Omar ZMM, Rashwan EK, Mohammedsaleh ZM, et al. Apocynin abrogates methotrexate-induced nephrotoxicity: role of TLR4\/NF-\u03baB-p65\/p38-MAPK, IL-6\/STAT-3, PPAR-\u03b3, and SIRT1\/FOXO3 signaling pathways. Arch Pharm Res. 2023;46:339\u201359.","journal-title":"Arch Pharm Res"},{"key":"902_CR174","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5653\/cerm.2020.04105","volume":"48","author":"L Kilinc","year":"2021","unstructured":"Kilinc L, Uz YH. Protective effects of curcumin against methotrexate-induced testicular damage in rats by suppression of the p38-MAPK and nuclear factor-kappa B pathways. Clin Exp Reprod Med. 2021;48:211\u201320.","journal-title":"Clin Exp Reprod Med"},{"key":"902_CR175","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuro.2022.07.005","volume":"92","author":"SA Abd El-Aal","year":"2022","unstructured":"Abd El-Aal SA, AbdElrahman M, Reda AM, Afify H, Ragab GM, El-Gazar AA, et al. Galangin mitigates DOX-induced cognitive impairment in rats: implication of NOX-1\/Nrf-2\/HMGB1\/TLR4 and TNF-\u03b1. Neurotoxicology. 2022;92:77\u201390.","journal-title":"Neurotoxicology"},{"key":"902_CR176","doi-asserted-by":"publisher","first-page":"103348","DOI":"10.1016\/j.neuro.2025.103348","volume":"111","author":"AM Shaheen","year":"2025","unstructured":"Shaheen AM, Sayed RH, Helal GK, El-Yamany MF, Fahmy MI. Dapagliflozin ameliorates cisplatin-induced cognitive impairments in rats: Cross-talk between miRNA-21\/p-ERK\/p-38 MAPK and wnt\/\u03b2-catenin signaling pathways. Neurotoxicology. 2025;111:103348.","journal-title":"Neurotoxicology"},{"key":"902_CR177","doi-asserted-by":"publisher","first-page":"108414","DOI":"10.1016\/j.neuropharm.2020.108414","volume":"184","author":"D Paes","year":"2021","unstructured":"Paes D, Xie K, Wheeler DG, Zook D, Prickaerts J, Peters M. Inhibition of PDE2 and PDE4 synergistically improves memory consolidation processes. Neuropharmacology. 2021;184:108414.","journal-title":"Neuropharmacology"},{"key":"902_CR178","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13195-025-01869-6","volume":"17","author":"X Rong","year":"2025","unstructured":"Rong X, Yao X, Fang H, Saji J, Qian Y, Gu JX, et al. Dual PDE4\/10A inhibition restores CREB1 function and enhances neuronal resilience in models of Alzheimer\u2019s disease. Alzheimers Res Ther. 2025;17:231.","journal-title":"Alzheimers Res Ther"},{"key":"902_CR179","doi-asserted-by":"publisher","first-page":"114245","DOI":"10.1016\/j.biopha.2023.114238","volume":"159","author":"AMA Mahmoud","year":"2023","unstructured":"Mahmoud AMA, Mantawy EM, Wahdan SA, Ammar RM, El-Demerdash E. Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: imperative roles of AMPK\/Akt\/CREB\/BDNF signaling cascades. Biomed Pharmacother. 2023;159:114245.","journal-title":"Biomed Pharmacother"},{"key":"902_CR180","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.bbi.2012.05.017","volume":"30","author":"S Kesler","year":"2013","unstructured":"Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013;30:S109\u201316.","journal-title":"Brain Behav Immun"},{"key":"902_CR181","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11682-013-9243-2","volume":"7","author":"KL Pomykala","year":"2013","unstructured":"Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Mallam S, et al. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav. 2013;7:511\u201323.","journal-title":"Brain Imaging Behav"},{"key":"902_CR182","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","volume":"26","author":"YT Cheung","year":"2015","unstructured":"Cheung YT, Ng T, Shwe M, Ho HK, Foo KM, Cham MT, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective cohort study. Ann Oncol. 2015;26:1446\u201351.","journal-title":"Ann Oncol"},{"key":"902_CR183","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12282-025-01668-9","volume":"32","author":"S-I Wu","year":"2025","unstructured":"Wu S-I, Chen C-H, Hsu Y-H, Tzang B-S, Stewart R, et al. Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer: a prospective follow-up study. Breast Cancer. 2025;32:470\u201380.","journal-title":"Breast Cancer"},{"key":"902_CR184","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/ijc.30252","volume":"139","author":"HR Wardill","year":"2016","unstructured":"Wardill HR, Mander KA, Van Sebille YZA, Gibson RJ, Logan RM, Bowen JM, et al. Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer. 2016;139:2635\u201345.","journal-title":"Int J Cancer"},{"key":"902_CR185","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","volume":"117","author":"X Ren","year":"2017","unstructured":"Ren X, St. Clair DK, Butterfield DA. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacol Res. 2017;117:267\u201373.","journal-title":"Pharmacol Res"},{"key":"902_CR186","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217.","journal-title":"Signal Transduct Target Ther"},{"key":"902_CR187","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"902_CR188","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2016.11.028","volume":"637","author":"J Cheng","year":"2017","unstructured":"Cheng J, Liu X, Cao L, Zhang T, Li H, Lin W. Neo-adjuvant chemotherapy with cisplatin induces low expression of NMDA receptors and postoperative cognitive impairment. Neurosci Lett. 2017;637:168\u201374.","journal-title":"Neurosci Lett"},{"key":"902_CR189","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.neuropharm.2011.07.013","volume":"61","author":"G Winocur","year":"2011","unstructured":"Winocur G, Binns MA, Tannock I. Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology. 2011;61:1222\u20138.","journal-title":"Neuropharmacology"},{"key":"902_CR190","doi-asserted-by":"publisher","first-page":"121312","DOI":"10.1016\/j.jep.2026.121312","volume":"361","author":"AY Labib","year":"2026","unstructured":"Labib AY, Assal RA, Mantawy EM, Tadros MG, Michel HE. Urolithin A counteracts cyclophosphamide-induced chemobrain in rats through modulation of mitochondrial signaling pathways. J Ethnopharmacol. 2026;361:121312.","journal-title":"J Ethnopharmacol"},{"key":"902_CR191","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbi.2025.06.037","volume":"129","author":"AK Singh","year":"2025","unstructured":"Singh AK, Ruiz D, Pandey VK, Ur Rasheed MS, Turner DJL, Avery TD, et al. Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in mice. Brain Behav Immun. 2025;129:547\u201356.","journal-title":"Brain Behav Immun"},{"key":"902_CR192","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","volume":"176","author":"EM Gibson","year":"2019","unstructured":"Gibson EM, Nagaraja S, Ocampo A, Tam LT, Wood LS, Pallegar PN, et al. Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell. 2019;176:43\u2013e5513.","journal-title":"Cell"},{"key":"902_CR193","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s12035-022-03136-3","volume":"60","author":"CB Subramaniam","year":"2023","unstructured":"Subramaniam CB, Wardill HR, Davies MR, Heng V, Gladman MA, Bowen JM. 5-Fluorouracil induces an acute reduction in neurogenesis and persistent neuroinflammation in a mouse model of the neuropsychological complications of chemotherapy. Mol Neurobiol. 2023;60:1408\u201324.","journal-title":"Mol Neurobiol"},{"key":"902_CR194","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"902_CR195","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1111\/jnc.70024","volume":"169","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang H, Augenreich M, Martinez-Lemus AL, Liu Z, Kang X, et al. Microglia-mediated synaptic dysfunction contributes to chemotherapy-related cognitive impairment. J Neurochem. 2025;169:e70024.","journal-title":"J Neurochem"},{"key":"902_CR196","doi-asserted-by":"publisher","first-page":"610813","DOI":"10.1155\/2015\/610813","volume":"2015","author":"R Fischer","year":"2015","unstructured":"Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev. 2015;2015:610813.","journal-title":"Oxid Med Cell Longev"},{"key":"902_CR197","doi-asserted-by":"publisher","first-page":"307","DOI":"10.14336\/AD.2015.1022","volume":"7","author":"AM Gaman","year":"2016","unstructured":"Gaman AM, Uzoni A, Popa-Wagner A, Andrei A, Petcu EB. the role of oxidative stress in etiopathogenesis of chemotherapy induced cognitive impairment (CICI) - chemobrain. Aging Dis. 2016;7:307\u201317.","journal-title":"Aging Dis"},{"key":"902_CR198","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.freeradbiomed.2011.03.009","volume":"50","author":"CD Aluise","year":"2011","unstructured":"Aluise CD, Miriyala S, Noel T, Sultana R, Jungsuwadee P, Taylor TJ, et al. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-\u03b1 release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radic Biol Med. 2011;50:1630\u20138.","journal-title":"Free Radic Biol Med"},{"key":"902_CR199","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2006.02.013","volume":"23","author":"J Tangpong","year":"2006","unstructured":"Tangpong J, Cole MP, Sultana R, Joshi G, Estus S, Vore M, et al. Adriamycin-induced, TNF-\u03b1-mediated central nervous system toxicity. Neurobiol Dis. 2006;23:127\u201339.","journal-title":"Neurobiol Dis"},{"key":"902_CR200","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/BPL-220143","volume":"8","author":"MA Rashid","year":"2022","unstructured":"Rashid MA, Oliveros A, Kim YS, Jang M-H. Nicotinamide mononucleotide prevents cisplatin-induced mitochondrial defects in cortical neurons derived from human induced pluripotent stem cells. Brain Plast. 2022;8:143\u201352.","journal-title":"Brain Plast"},{"key":"902_CR201","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12035-023-03559-6","volume":"61","author":"R Lal","year":"2023","unstructured":"Lal R, Dharavath RN, Chopra K. Nrf2 signaling pathway: a potential therapeutic target in combating oxidative stress and neurotoxicity in chemotherapy-induced cognitive impairment. Mol Neurobiol. 2023;61:593\u2013608.","journal-title":"Mol Neurobiol"},{"key":"902_CR202","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1007\/s12035-024-04499-5","volume":"62","author":"RM Abdelsalam","year":"2025","unstructured":"Abdelsalam RM, Hamam HW, Eissa NM, El-Sahar AE, Essam RM. Empagliflozin dampens doxorubicin-induced chemobrain in rats: The possible involvement of oxidative stress and PI3K\/Akt\/mTOR\/NF-\u03baB\/TNF-\u03b1 signaling pathways. Mol Neurobiol. 2025;62:3480\u201392.","journal-title":"Mol Neurobiol"},{"key":"902_CR203","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2016.08.003","volume":"791","author":"A Jangra","year":"2016","unstructured":"Jangra A, Kwatra M, Singh T, Pant R, Kushwah P, Ahmed S, et al. Edaravone alleviates cisplatin-induced neurobehavioral deficits via modulation of oxidative stress and inflammatory mediators in the rat hippocampus. Eur J Pharmacol. 2016;791:51\u201361.","journal-title":"Eur J Pharmacol"},{"key":"902_CR204","doi-asserted-by":"publisher","first-page":"116886","DOI":"10.1016\/j.lfs.2019.116867","volume":"236","author":"A Iqubal","year":"2019","unstructured":"Iqubal A, Sharma S, Najmi AK, Syed MA, Ali J, Alam MM, et al. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: plausible role of Nrf2 and NF-\u03baB. Life Sci. 2019;236:116886.","journal-title":"Life Sci"},{"key":"902_CR205","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1200\/JCO.2012.46.7944","volume":"31","author":"KR Krull","year":"2013","unstructured":"Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, et al. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013;31:2182\u20138.","journal-title":"J Clin Oncol"},{"key":"902_CR206","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2014.59.0273","volume":"33","author":"PD Cole","year":"2015","unstructured":"Cole PD, Finkelstein Y, Stevenson KE, Blonquist TM, Vijayanathan V, Silverman LB, et al. Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2015;33:2205\u201311.","journal-title":"J Clin Oncol"},{"key":"902_CR207","doi-asserted-by":"publisher","first-page":"12697","DOI":"10.3390\/ijms222312697","volume":"22","author":"MJ Sekeres","year":"2021","unstructured":"Sekeres MJ, Bradley-Garcia M, Martinez-Canabal A, Winocur G. Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: a review of physiological mechanisms and interventions. Int J Mol Sci. 2021;22:12697.","journal-title":"Int J Mol Sci"},{"key":"902_CR208","doi-asserted-by":"publisher","first-page":"110651","DOI":"10.1016\/j.biopha.2020.110651","volume":"131","author":"N Sritawan","year":"2020","unstructured":"Sritawan N, Prajit R, Chaisawang P, Sirichoat A, Pannangrong W, Wigmore P, et al. Metformin alleviates memory and hippocampal neurogenesis decline induced by methotrexate chemotherapy in a rat model. Biomed Pharmacother. 2020;131:110651.","journal-title":"Biomed Pharmacother"},{"key":"902_CR209","doi-asserted-by":"publisher","first-page":"117468","DOI":"10.1016\/j.lfs.2020.117468","volume":"248","author":"A Sirichoat","year":"2020","unstructured":"Sirichoat A, Suwannakot K, Chaisawang P, Pannangrong W, Aranarochana A, Wigmore P, et al. Melatonin attenuates 5-fluorouracil-induced spatial memory and hippocampal neurogenesis impairment in adult rats. Life Sci. 2020;248:117468.","journal-title":"Life Sci"},{"key":"902_CR210","doi-asserted-by":"publisher","first-page":"104715","DOI":"10.1016\/j.nbd.2019.104715","volume":"136","author":"LT Yi","year":"2020","unstructured":"Yi LT, Dong SQ, Wang SS, Chen M, Li CF, Geng D, et al. Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy. Neurobiol Dis. 2020;136:104715.","journal-title":"Neurobiol Dis"},{"key":"902_CR211","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/jbiol50","volume":"5","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Han R, Yang Y, Mayer-Pr\u00f6schel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006;5:22.","journal-title":"J Biol"},{"key":"902_CR212","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neuropharm.2018.02.013","volume":"133","author":"HS Park","year":"2018","unstructured":"Park HS, Kim CJ, Kwak HB, No MH, Heo JW, Kim TW. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain. Neuropharmacology. 2018;133:451\u201361.","journal-title":"Neuropharmacology"},{"key":"902_CR213","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nlm.2017.08.001","volume":"144","author":"D Panoz-Brown","year":"2017","unstructured":"Panoz-Brown D, Carey LM, Smith AE, Gentry M, Sluka CM, Corbin HE, et al. The chemotherapeutic agent paclitaxel selectively impairs reversal learning while sparing prior learning, new learning and episodic memory. Neurobiol Learn Mem. 2017;144:259\u201370.","journal-title":"Neurobiol Learn Mem"},{"key":"902_CR214","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","volume":"112","author":"MF Egan","year":"2003","unstructured":"Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257\u201369.","journal-title":"Cell"},{"key":"902_CR215","doi-asserted-by":"publisher","first-page":"523","DOI":"10.14336\/AD.2017.0717","volume":"9","author":"T Shen","year":"2018","unstructured":"Shen T, You Y, Joseph C, Mirzaei M, Klistorner A, Graham SL, et al. BDNF polymorphism: a review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis. 2018;9:523\u201336.","journal-title":"Aging Dis"},{"key":"902_CR216","doi-asserted-by":"publisher","first-page":"16298","DOI":"10.1038\/s41598-023-43581-1","volume":"13","author":"DQ Ng","year":"2023","unstructured":"Ng DQ, Cheng I, Wang C, Tan CJ, Toh YL, Koh YQ, et al. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients. Sci Rep. 2023;13:16298.","journal-title":"Sci Rep"},{"key":"902_CR217","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","volume":"103","author":"AC Geraghty","year":"2019","unstructured":"Geraghty AC, Gibson EM, Ghanem RA, Greene JJ, Ocampo A, Goldstein AK, et al. Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment. Neuron. 2019;103:250\u2013e2658.","journal-title":"Neuron"},{"key":"902_CR218","doi-asserted-by":"publisher","first-page":"1188672","DOI":"10.3389\/fncel.2023.1188672","volume":"17","author":"T Charlton","year":"2023","unstructured":"Charlton T, Prowse N, McFee A, Heiratifar N, Fortin T, Paquette C, et al. Brain-derived neurotrophic factor (BDNF) has direct anti-inflammatory effects on microglia. Front Cell Neurosci. 2023;17:1188672.","journal-title":"Front Cell Neurosci"},{"key":"902_CR219","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1126\/science.aab4138","volume":"351","author":"EQ Toyama","year":"2016","unstructured":"Toyama EQ, Herzig S, Courchet J, Lewis TL, Los\u00f3n OC, Hellberg K, et al. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science. 2016;351:275\u201381.","journal-title":"Science"},{"key":"902_CR220","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-cellbio-120420-094431","volume":"41","author":"N Malik","year":"2025","unstructured":"Malik N, Shaw RJ. The AMPK pathway: molecular rejuvenation of metabolism and mitochondria. Annu Rev Cell Dev Biol. 2025;41:375\u2013402.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"902_CR221","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/cns.12404","volume":"21","author":"E Kornelius","year":"2015","unstructured":"Kornelius E, Lin CL, Chang HH, Li HH, Huang WN, Yang YS, et al. DPP-4 inhibitor linagliptin attenuates A\u03b2-induced cytotoxicity through activation of AMPK in neuronal cells. CNS Neurosci Ther. 2015;21:549\u201357.","journal-title":"CNS Neurosci Ther"},{"key":"902_CR222","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","volume":"347","author":"MC Chiang","year":"2016","unstructured":"Chiang MC, Cheng YC, Chen SJ, Yen CH, Huang RN. Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction. Exp Cell Res. 2016;347:322\u201331.","journal-title":"Exp Cell Res"},{"key":"902_CR223","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","volume":"12","author":"K Hughes","year":"1993","unstructured":"Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 1993;12:803\u20138.","journal-title":"EMBO J"},{"key":"902_CR224","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1042\/bj3030701","volume":"303","author":"V Stambolic","year":"1994","unstructured":"Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J. 1994;303:701\u20134.","journal-title":"Biochem J"},{"key":"902_CR225","doi-asserted-by":"publisher","first-page":"12619","DOI":"10.1523\/JNEUROSCI.0659-13.2013","volume":"33","author":"AM Fortress","year":"2013","unstructured":"Fortress AM, Schram SL, Tuscher JJ, Frick KM. Canonical Wnt signaling is necessary for object recognition memory consolidation. J Neurosci. 2013;33:12619\u201326.","journal-title":"J Neurosci"},{"key":"902_CR226","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1007\/s12035-023-03910-x","volume":"61","author":"W Li","year":"2024","unstructured":"Li W, Gan C, Yu S, Xu J, Tang LX, Cheng H. Wnt3a\/GSK3\u03b2\/\u03b2-catenin signalling modulates doxorubicin-associated memory deficits in breast cancer. Mol Neurobiol. 2024;61:5441\u201358.","journal-title":"Mol Neurobiol"},{"key":"902_CR227","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbr.2015.04.044","volume":"290","author":"CK Callaghan","year":"2015","unstructured":"Callaghan CK, O\u2019Mara SM. Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram. Behav Brain Res. 2015;290:84\u20139.","journal-title":"Behav Brain Res"},{"key":"902_CR228","doi-asserted-by":"publisher","first-page":"123378","DOI":"10.1016\/j.lfs.2025.123378","volume":"362","author":"G Eskander","year":"2025","unstructured":"Eskander G, Abdelhamid SG, Wahdan SA, Radwan SM. Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3\/ASC\/caspase-1\/GSDMD axis. Life Sci. 2025;362:123378.","journal-title":"Life Sci"},{"key":"902_CR229","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2377-13-153","volume":"13","author":"J Davis","year":"2013","unstructured":"Davis J, Ahlberg FM, Berk M, Ashley DM, Khasraw M. Emerging pharmacotherapy for cancer patients with cognitive dysfunction. BMC Neurol. 2013;13:153.","journal-title":"BMC Neurol"},{"key":"902_CR230","doi-asserted-by":"publisher","first-page":"146344","DOI":"10.1016\/j.brainres.2019.146344","volume":"1722","author":"L Zhu","year":"2019","unstructured":"Zhu L, Zhang Z, Hou X-J, Wang Y-F, Yang J-Y, Wu C-F. Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model. Brain Res. 2019;1722:146344.","journal-title":"Brain Res"},{"key":"902_CR231","doi-asserted-by":"publisher","first-page":"351923","DOI":"10.3389\/fnbeh.2018.00104","volume":"12","author":"JE Bajic","year":"2018","unstructured":"Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the bottom-up: Chemotherapy and gut-brain axis dysregulation. Front Behav Neurosci. 2018;12:351923.","journal-title":"Front Behav Neurosci"},{"key":"902_CR232","doi-asserted-by":"publisher","first-page":"16490","DOI":"10.1038\/s41598-019-52893-0","volume":"9","author":"BR Loman","year":"2019","unstructured":"Loman BR, Jordan KR, Haynes B, Bailey MT, Pyter LM. Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice. Sci Rep. 2019;9:16490.","journal-title":"Sci Rep"},{"key":"902_CR233","doi-asserted-by":"publisher","first-page":"e0284365","DOI":"10.1371\/journal.pone.0284365","volume":"18","author":"CV Grant","year":"2023","unstructured":"Grant CV, Jordan K, Seng MM, Pyter LM. Antibiotic treatment inhibits paclitaxel chemotherapy-induced activity deficits in female mice. PLoS ONE. 2023;18:e0284365.","journal-title":"PLoS ONE"},{"key":"902_CR234","doi-asserted-by":"publisher","first-page":"27448","DOI":"10.1038\/s41598-025-12352-5","volume":"15","author":"C Patel","year":"2025","unstructured":"Patel C, Willekens J, Diglio F, Cole PD. Doxorubicin causes cognitive impairment and alters gut microbiota in both male and female juvenile rats. Sci Rep. 2025;15:27448.","journal-title":"Sci Rep"},{"key":"902_CR235","doi-asserted-by":"publisher","first-page":"135720","DOI":"10.1016\/j.neulet.2021.135720","volume":"749","author":"N Lomeli","year":"2021","unstructured":"Lomeli N, Lepe J, Gupta K, Bota DA. Cognitive complications of cancer and cancer-related treatments - Novel paradigms. Neurosci Lett. 2021;749:135720.","journal-title":"Neurosci Lett"},{"key":"902_CR236","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s12672-025-03802-7","volume":"16","author":"B Zhang","year":"2025","unstructured":"Zhang B, Lau LY, Wu Z, Chen Y. Chemotherapy induced neurotoxicity in cancer survivors assessed through a dual database bibliometric analysis from 2005 to 2025. Discov Oncol. 2025;16:1961.","journal-title":"Discov Oncol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00902-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:01:58Z","timestamp":1789714918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00902-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":236,"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00902-1","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used ChatGPT for creation of figures. The final content of the article is the authors\u2019 own responsibility.","order":2,"name":"Ethics","label":"Disclosure of using artificial intelligence (AI)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}